Wells Fargo Upgrades Eli Lilly to Overweight, Raises Price Target to $375
Wells Fargo analyst Mohit Bansal upgrades Eli Lilly (NYSE:LLY) from Equal-Weight to Overweight and raises the price target from $360 to $375.
Wells Fargo Upgrades JPMorgan Chase to Overweight, Raises Price Target to $155
Wells Fargo analyst Mike Mayo upgrades JPMorgan Chase (NYSE:JPM) from Equal-Weight to Overweight and raises the price target from $148 to $155.
Keefe, Bruyette & Woods Upgrades Truist Finl to Market Perform, Lowers Price Target to $45
Keefe, Bruyette & Woods analyst David Konrad upgrades Truist Finl (NYSE:TFC) from Underperform to Market Perform and lowers the price target from $47 to $45.
A Bull Case For Marathon Petroleum As Margins For Refining Become More Profitable
Oil refining and transportation company Marathon Petroleum Corp (NYSE:MPC) received positive analysis from Mizuho securities analysts looking at…
Evercore ISI Group Upgrades Bionomics to Outperform, Announces $6 Price Target
Evercore ISI Group analyst Joshua Schimmer upgrades Bionomics (NASDAQ:BNOX) from In-Line to Outperform and announces $6 price target.
Jefferies Upgrades Roblox to Buy, Raises Price Target to $48
Jefferies analyst Andrew Uerkwitz upgrades Roblox (NYSE:RBLX) from Hold to Buy and raises the price target from $30 to $48.
Piper Sandler Upgrades KeyCorp to Neutral, Lowers Price Target to $16.5
Piper Sandler analyst Scott Siefers upgrades KeyCorp (NYSE:KEY) from Underweight to Neutral and lowers the price target from $18.5 to $16.5.
Baird Upgrades KeyCorp to Outperform, Announces $20 Price Target
Baird analyst David George upgrades KeyCorp (NYSE:KEY) from Neutral to Outperform and announces $20 price target.
Citigroup Upgrades Silk Road Medical to Neutral
Citigroup analyst Joanne Wuensch upgrades Silk Road Medical (NASDAQ:SILK) from Sell to Neutral.
Barclays Upgrades United Airlines Holdings to Overweight, Raises Price Target to $80
Barclays analyst Brandon Oglenski upgrades United Airlines Holdings (NASDAQ:UAL) from Equal-Weight to Overweight and raises the price target from $52 to $80.